Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for STAAR Surgical Company (STAA : NSDQ)

• Company Description    Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. Number of Employees: 1,211

• Price / Volume Information    Yesterday's Closing Price: $17.56 Daily Weekly Monthly 20 Day Moving Average: 801,808 shares Shares Outstanding: 49.53 (millions) Market Capitalization: $869.68 (millions) Beta: 0.58 52 Week High: $49.86 52 Week Low: $13.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.34% 1.00% 12 Week 10.65% -3.04% Year To Date -27.71% -31.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 25510 COMMERCENTRE DRIVE - LAKE FOREST,CA 92630 USA ph: 626-303-7902 fax: 626-303-2962 bmoore@staar.com http://www.staar.com

• General Corporate Information    Officers Thomas G. Frinzi - President; Chief Executive Officer and Chairman Patrick F. Williams - Vice President; Chief Financial Officer Arthur C. Butcher - Director Stephen C. Farrell - Director Wei Jiang - Director Peer Information STAAR Surgical Company (ITRJ) STAAR Surgical Company (BRLI.) STAAR Surgical Company (GOGY) STAAR Surgical Company (PSTX.) STAAR Surgical Company (ELGXQ) STAAR Surgical Company (CAH) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED/DENTAL-SUPP Sector: Medical CUSIP: 852312305 SIC: 3851 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 49.53 Most Recent Split Date: 5.00 (0.50:1) Beta: 0.58 Market Capitalization: $869.68 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.26 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.48 Price/Cash Flow: - Price / Sales: 3.12 EPS Growth vs. Year Ago Period: -814.29% vs. Previous Quarter: -8.47% Sales Growth vs. Year Ago Period: -44.94% vs. Previous Quarter: -12.99% ROE 06/30/25 - - 03/31/25 - -10.59 12/31/24 - -3.38 ROA 06/30/25 - - 03/31/25 - -8.32 12/31/24 - -2.68 Current Ratio 06/30/25 - - 03/31/25 - 4.78 12/31/24 - 5.23 Quick Ratio 06/30/25 - - 03/31/25 - 4.07 12/31/24 - 4.62 Operating Margin 06/30/25 - - 03/31/25 - -15.03 12/31/24 - -4.38 Net Margin 06/30/25 - - 03/31/25 - -25.46 12/31/24 - -6.44 Pre-Tax Margin 06/30/25 - - 03/31/25 - -21.97 12/31/24 - -2.88 Book Value 06/30/25 - - 03/31/25 - 7.07 12/31/24 - 8.06 Inventory Turnover 06/30/25 - - 03/31/25 - 1.70 12/31/24 - 1.84 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©